vs

Side-by-side financial comparison of Ascent Solar Technologies, Inc. (ASTI) and InflaRx N.V. (IFRX). Click either name above to swap in a different company.

InflaRx N.V. is the larger business by last-quarter revenue ($25.7K vs $15.6K, roughly 1.6× Ascent Solar Technologies, Inc.).

Ascent Solar Technologies, Inc. is a publicly traded photovoltaic (PV) company located in Thornton, Colorado. Its primary product is a flexible CIGS solar cell on a plastic substrate.

InflaRx N.V. is a clinical-stage biopharmaceutical company specializing in the development of novel anti-inflammatory therapies targeting the complement C5a pathway. Its pipeline addresses unmet medical needs for severe inflammatory diseases including autoimmune and rare inflammatory disorders, serving global patient populations.

ASTI vs IFRX — Head-to-Head

Bigger by revenue
IFRX
IFRX
1.6× larger
IFRX
$25.7K
$15.6K
ASTI

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASTI
ASTI
IFRX
IFRX
Revenue
$15.6K
$25.7K
Net Profit
Gross Margin
98.6%
Operating Margin
Net Margin
Revenue YoY
Net Profit YoY
-42.3%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTI
ASTI
IFRX
IFRX
Q4 25
$15.6K
Q3 25
$28.5K
$25.7K
Q2 25
$17.0K
$42.6K
Q1 25
$15.6K
Q4 24
$0
Q3 24
$8.6K
Q2 24
$27.7K
$6.9K
Q1 24
$5.6K
Net Profit
ASTI
ASTI
IFRX
IFRX
Q4 25
Q3 25
$-2.0M
Q2 25
$-2.1M
$-15.6M
Q1 25
$-1.7M
Q4 24
$-1.5M
Q3 24
$-1.7M
Q2 24
$-3.4M
$-15.0M
Q1 24
$-2.5M
Gross Margin
ASTI
ASTI
IFRX
IFRX
Q4 25
Q3 25
98.6%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ASTI
ASTI
IFRX
IFRX
Q4 25
Q3 25
-6892.3%
Q2 25
-12316.8%
Q1 25
-11177.9%
Q4 24
Q3 24
-26443.2%
Q2 24
-8490.7%
Q1 24
-44206.0%
Net Margin
ASTI
ASTI
IFRX
IFRX
Q4 25
Q3 25
-7081.3%
Q2 25
-12177.3%
-36559.8%
Q1 25
-10716.2%
Q4 24
Q3 24
-19776.2%
Q2 24
-12420.5%
-217803.1%
Q1 24
-45316.8%
EPS (diluted)
ASTI
ASTI
IFRX
IFRX
Q4 25
Q3 25
$-0.62
Q2 25
$-1.17
Q1 25
$-1.13
Q4 24
$50.75
Q3 24
$-1.37
Q2 24
$-6.76
Q1 24
$-53.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTI
ASTI
IFRX
IFRX
Cash + ST InvestmentsLiquidity on hand
$2.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.3M
Total Assets
$6.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTI
ASTI
IFRX
IFRX
Q4 25
$2.8M
Q3 25
$2.1M
Q2 25
$3.0M
$14.0M
Q1 25
$2.3M
Q4 24
$3.2M
Q3 24
$3.7M
Q2 24
$5.8M
$20.7M
Q1 24
$187.5K
Stockholders' Equity
ASTI
ASTI
IFRX
IFRX
Q4 25
$3.3M
Q3 25
$2.7M
Q2 25
$3.4M
$61.6M
Q1 25
$2.6M
Q4 24
$3.4M
Q3 24
$-3.3M
Q2 24
$4.2M
$88.7M
Q1 24
$-2.6M
Total Assets
ASTI
ASTI
IFRX
IFRX
Q4 25
$6.3M
Q3 25
$5.8M
Q2 25
$6.8M
$79.3M
Q1 25
$6.2M
Q4 24
$7.1M
Q3 24
$7.9M
Q2 24
$10.2M
$100.5M
Q1 24
$5.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTI
ASTI
IFRX
IFRX
Operating Cash FlowLast quarter
$-6.9M
$-33.1M
Free Cash FlowOCF − Capex
$-6.9M
FCF MarginFCF / Revenue
-44350.5%
Capex IntensityCapex / Revenue
204.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTI
ASTI
IFRX
IFRX
Q4 25
$-6.9M
Q3 25
$-1.7M
$-33.1M
Q2 25
$-1.8M
Q1 25
$-1.6M
Q4 24
$-1.5M
Q3 24
$-2.1M
Q2 24
$-3.6M
$-29.2M
Q1 24
$-1.2M
Free Cash Flow
ASTI
ASTI
IFRX
IFRX
Q4 25
$-6.9M
Q3 25
$-1.8M
Q2 25
$-1.8M
Q1 25
$-1.6M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
ASTI
ASTI
IFRX
IFRX
Q4 25
-44350.5%
Q3 25
-6182.5%
Q2 25
-10692.4%
Q1 25
-9923.9%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
ASTI
ASTI
IFRX
IFRX
Q4 25
204.7%
Q3 25
103.3%
Q2 25
12.0%
Q1 25
3.1%
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons